Our Healthcare Portfolio.
Access Telehealth is a virtual clinic Telehealth provider of specialist care to Rural Australia, as well as offering NDIS and Aged Care solutions.
AI Therapeutics utilises artificial intelligence to precisely match drugs to new disease indications, speeding up discovery and trials to provide the best care for patients.
Butterfly Network is a digital health company that has pioneered the worlds first handheld whole-body ultrasound system.
Listed on the NYSE (BFLY) in February 2021.
Celsee is a single-cell analysis company, with applications including single-cell cytometry, proteogenomics, transcriptomics, and rare-cell enumeration.
Acquired by Bio-Rad in April 2020.
Cleaflow’s technology advances healing in cardiac surgery by preventing post-operative complications associated with retained blood and fluid.
Decipher is a precision oncology company providing information on the underlying biology of a patient's tumour, assisting the selection of optimal therapies. Acquired by Veracyte in May 2021.
Detect is developing at-home novel Nucleic Acid tests to power the next generation of viral and bacteria diagnostics. Detect provides PCR-quality COVID-19 testing at home in 1 hour.
Hyperfine has developed the world’s first portable and affordable point-of-care MRI system, democratising access to medical imaging.
Listed on the NASDAQ (HYPR) in December 2021.
Jiff serves as a central hub for wellbeing and other benefit programs for Employers.
Acquired by Castlight in April 2017.
Jump is a hospital supply chain and analytics company that helps manage hospital inventories and automates the tracking of medical supplies.
Kit Check’s suite of integrated Medication Intelligence solutions bring visibility, simplicity, and predictability to the complex world of medication supply management. Kit Check helps hospitals manage the entire medication lifecycle with actionable analytics.
Leon's expertise in nanotechnology enables its pharmaceutical partners to access a new level of innovation and improved patient outcomes. Leon combines novel techniques with a validated approach, enabling formulations to be delivered with increased solubility and improved bioavailability.
Liminal is building a medical device to non-invasively measure key vital signs in the brain, enabling unprecedented neurological access to dramatically improve patient outcomes.
Merged with Hyperfine in December 2021.
PFS is a molecular diagnostics company that informs clinicians whether radiation therapy will benefit breast cancer patients.
Acquired by Exact Sciences Corp in May 2021.
QuantumSi is developing the next generation protein sequencing platform of the future. Powered by proprietary semiconductor technology, Q-Si's platform enables single molecule resolution, generating powerful biological insights.
Listed on the NASDAQ (QSI) in June 2021.
Sanguine bridges the gap between medical researchers and patients to accelerate discovery and development. Sanguine's unique patient-centric biospecimen and data collection creates a better patient experience while delivering a more clinically-relevant view of biology
Sherlock Biosciences is developing next-generation point-of-need diagnostics platforms to democratise access to health information. Powered by CRISPR and synthetic biology, Sherlock's diagnostics platforms will offer PCR-level accuracy with the affordability and convenience of rapid antigen tests.
Stride delivers affordable benefits to independent workers. Stride partners with companies such as Uber and Amazon, providing gig economy workers with benefits traditionally provided by employers.
The eye is the window into one's health. Tesseract is creating a non-invasive test that detects health conditions through the eyes, leveraging the wealth of information in the human eye to improve patient care.
Our Sustainability Portfolio.
AgBiome creates innovative and novel agricultural products, leveraging naturally occurring genetic variations from its proprietary microbial database.
Protein Evolution is developing a cell-free synthetic biology platform to create proteins that transform the health of the earth's environment and people.
Our Digital Portfolio.
Animoca Brands is a leading blockchain gaming company. Animoca develops and publishes its own products, including the REVV ecosystem and The Sandbox, and has a growing portfolio of over 150 investments in the industry.
CAIS is the leading alternative investment platform for financial advisors who seek improved access to and education about alternative investment funds and products.